Founded in 1995 and based in Silicon Valley and San Antonio, InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes. InCube Labs’ world-class, multi-disciplinary team has developed medical devices and drug-device combination therapies to address unmet clinical needs across a variety of therapeutic areas, from CNS and Cardiovascular to Metabolic, IBD and Renal Disease. Mir Imran, InCube’s founder and CEO, is recognized as one of the leading inventors and entrepreneurs in the field. Mir has founded more than 20 life sciences companies.
As an InCube company, we have access to knowledge, expertise and resources that allow us to efficiently build our company and execute.
InCube’s venture arm, InCube Ventures, has multiple funds focused on the convergence of pharma, biologics and devices. InCube Ventures has a diversified portfolio of early, mid and late stage life sciences companies, which includes Rani Therapeutics.
InCube Labs is a multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations. We seek to understand the biggest challenges in healthcare and develop innovative and effective treatment solutions that have the potential to improve the lives of millions of patients.
VentureHealth is a crowdfunding portal focused on the healthcare sector. VentureHealth provides accredited investors with access to high growth opportunities in the $2.5 trillion healthcare sector. VentureHealth’s mission is to dramatically transform clinical outcomes by capitalizing breakthrough innovations. Venture Health is also an investor in Rani Therapeutics.